Category
page 1Coagulopathies

thrombocytopenia
In hematology, thrombocytopenia is a condition characterized by abnormally low levels of platelets (also known as thrombocytes) in the blood. Low levels of platelets in turn may lead to prolonged or excessive bleeding. It is the most common coagulation disorder among intensive care patients and is seen in a fifth of medical patients and a third of surgical patients.
disseminated intravascular coagulation
pathological process characterized by the widespread activation of the clotting cascade that results in the formation of blood clots in the small blood vessels throughout the body
autoimmune thrombocytopenic purpura
primary thrombocytopenia that involves relatively few platelets in blood as a result of autoantibodies
deep vein thrombosis
formation of a blood clot (thrombus) in a deep vein
von Willebrand's disease
blood-clotting disorder
antiphospholipid syndrome
human disease
.jpg)
thrombogavitis
thumb|Histopathological image representing a [[bone marrow aspirate in a patient with essential thrombocythemia]]
blood coagulation disease
Coagulopathy (also called a bleeding disorder) is a condition in which the blood's ability to coagulate (form clots) is impaired. This condition can cause a tendency toward prolonged or excessive bleeding (bleeding diathesis), which may occur spontaneously or following an injury or medical and dental procedures.
thrombotic thrombocytopenic purpura
human disease

thrombophilia
Thrombophilia (sometimes called hypercoagulability or a prothrombotic state) is an abnormality of blood coagulation that increases the risk of thrombosis (blood clots in blood vessels). Such abnormalities can be identified in 50% of people who have an episode of thrombosis (such as deep vein thrombosis in the leg) that was not provoked by other causes. A significant proportion of the population has a detectable thrombophilic abnormality, but most of these develop thrombosis only in the presence of an additional risk factor.
hemophilia A
X-linked disease that has material basis in Factor VIII deficiency, which results in the formation of fibrin deficient clots which makes coagulation much more prolonged
hemophilia B
inherited blood coagulation disease that has material basis in Factor IX deficiency, which makes coagulation much more prolonged. The disease is inherited as an X-linked recessive trait
hemorrhagic disease
human disease
essential thrombocytosis
human disease
heparin-induced thrombocytopenia
development of thrombocytopenia (a low platelet count), due to the administration of various forms of heparin, an anticoagulant
Glanzmann's thrombasthenia
human disease
Factor V Leiden
variant causing increased blood clotting
Bernard-Soulier syndrome
Human disease
cavernous sinus thrombosis
Human disease
Evans' syndrome
Human disease
Hermansky-Pudlak syndrome
rare disease
thrombotic microangiopathy
pathology that results in thrombosis in capillaries and arterioles, due to an endothelial injury
superficial vein thrombosis
Blood clot in a vein near the skin surface
Kasabach-Merritt syndrome
rare disease usually seen in infants
thrombocytopenic purpura
human disease
hypercoagulability in pregnancy
medical condition
May–Hegglin anomaly
medical condition
antithrombin III deficiency
inherited blood coagulation disease characterized by the tendency to form clots in the veins
protein S deficiency
disorder associated with increased risk of venous thrombosis
neonatal alloimmune thrombocytopenia
platelet-related disease affecting fetuses and infants, which can be fatal
activated protein C resistance
hemostatic disorder
protein C deficiency
rare genetic trait that predisposes to thrombotic disease
purpura fulminans
purpura characterized by blood spots, bruising and discolouration of the skin
hypoprothrombinemia
Hypoprothrombinemia is a rare blood disorder in which a deficiency in immunoreactive prothrombin (Factor II), produced in the liver, results in an impaired blood clotting reaction, leading to an increased physiological risk for spontaneous bleeding. This condition can be observed in the gastrointestinal system, cranial vault, and superficial integumentary system, affecting both the male and female population. Prothrombin is a critical protein that is involved in the process of hemostasis, as well as illustrating procoagulant activities. This condition is characterized as an autosomal recessive
gray platelet syndrome
rare congenital autosomal recessive bleeding disorder caused by a reduction or absence of alpha-granules in blood platelets